(Q40356366)

19 September 2017

title

A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation (English)

1 reference

19 September 2017

4

E Bernatowska

1 reference

19 September 2017

W Kreuz

1

1 reference

19 September 2017

M Erdös

2

1 reference

19 September 2017

P Rossi

3

1 reference

19 September 2017

T Espanol

5

1 reference

19 September 2017

L Maródi

6

1 reference

19 September 2017

publication date

1 September 2010

1 reference

Clinical and Experimental Immunology

19 September 2017

published in

1 reference

19 September 2017

volume

161

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

512-517

1 reference

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

19 September 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Clinical uses of intravenous immunoglobulin.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Intravenous immune globulins: an update for clinicians

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

The use of intravenous immune globulin in immunodeficiency diseases

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Intravenous immunoglobulin therapy for antibody deficiency

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2962969

Primary immunodeficiency diseases. Report of a WHO sponsored meeting

29 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20550545

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical and Immunological Spectrum of Common Variable Immunodeficiency (CVID)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20550545

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20550545

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2249.2010.04187.X

1 reference

19 September 2017

0 references

1 reference